BSE filing, NSE: RIDDHI. Summary written from the filing by ALFA Finder's alert engine.
Riddhi Siddhi Gluco Biols Ltd: key numbers
- Share price
- ₹679.80
- Market cap
- ₹484.7 Cr
- Revenue (annual)
- ₹235.8 Cr
- Net profit (annual)
- ₹-4.48 Cr
- P/E (TTM)
- -51.1×Sector 45.0×
- Promoter holding
- 75.00%+0.00% QoQ
- FII holding
- 2.67%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Riddhi Siddhi Gluco Biols Ltd
All →Riddhi Siddhi Gluco Biols Other Announcement
Riddhi Siddhi Gluco Biols Ltd has submitted its quarterly shareholding pattern as of September 30, 2026, in compliance with SEBI regulations.
Riddhi Siddhi Gluco Biols Other Announcement
Riddhi Siddhi Gluco Biols Limited has shifted its registered office from Gujarat to Haryana. Consequently, the company's Corporate Identification Number (CIN) has been updated.
Riddhi Siddhi Gluco Biols Management Change
Riddhi Siddhi Gluco Biols Limited has appointed Taral Shah as a Non-Executive Independent Director. Additionally, the company appointed Batliboi & Purohit as its new Statutory Auditor.
Riddhi Siddhi Gluco Biols Annual General Meeting
Riddhi Siddhi Gluco Biols Limited conducted its 35th Annual General Meeting on September 25, 2026, via video conferencing to transact items listed in the AGM notice.
Riddhi Siddhi Gluco Biols Other Announcement
Riddhi Siddhi Gluco Biols Limited has received regulatory approval to shift its registered office from the State of Gujarat to the State of Haryana.
Riddhi Siddhi Gluco Biols Annual General Meeting
Riddhi Siddhi Gluco Biols Limited has issued a notice for its 35th Annual General Meeting on September 25, 2026. The agenda includes financial approvals and business resolutions.
Other board meeting date announcements
All →VCU Data Management Board Meeting Date
VCU Data Management scheduled a board meeting for 6 November 2026. It will consider unaudited Q2 and half-year results for the period ended September 2026.
Eiko Lifesciences Board Meeting Date
Eiko Lifesciences has scheduled a board meeting for November 5, 2026, to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The trading window stays closed until 48 hours after the results.
EFORU Entertainment Board Meeting Date
Eforu Entertainment announced a board meeting on 05 November 2026 to consider unaudited quarterly and half-year results. Results remain unreported until the meeting is held.
Alpine Housing Development Corporation Board Meeting Date
Alpine Housing Development will hold a board meeting on 13 November 2026 to approve unaudited results for the quarter ended 30 September 2026. The trading window is closed from 1 October to 15 November 2026.
Mafia Trends Board Meeting Date
Mafia Trends will hold a board meeting on 5 November 2026 to consider unaudited standalone results for the quarter and half year ended 30 September 2026. The trading window remains closed until 48 hours after results are declared.
Paras Healthcare Board Meeting Date
Paras Healthcare will hold a board meeting on 5 November 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended 30 September 2026. The trading window stays closed until 48 hours after the results are declared.